null

SMILES: CCCCCNc1ncc(C(=O)Nc2ccc(cc2)S(=O)(=O)N2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1

InChI Key: InChIKey=HSKPWLBWANOLQJ-XUTJKUGGSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50444272   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase Mer (Homo sapiens (Human))	BDBM50444272 (CHEMBL3093626) Show SMILES CCCCCNc1ncc(C(=O)Nc2ccc(cc2)S(=O)(=O)N2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1 |r,wU:30.31,wD:33.35,(23.85,-22.37,;25.18,-23.14,;26.52,-22.37,;27.85,-23.14,;29.18,-22.37,;30.52,-23.14,;31.85,-22.37,;33.19,-23.14,;34.52,-22.37,;34.52,-20.82,;35.85,-20.05,;35.84,-18.51,;37.18,-20.81,;38.52,-20.04,;39.85,-20.81,;41.18,-20.03,;41.17,-18.49,;39.83,-17.73,;38.5,-18.51,;42.5,-17.71,;41.73,-16.37,;43.27,-16.37,;43.84,-18.48,;43.84,-20.01,;45.17,-20.78,;46.5,-20.01,;46.5,-18.46,;45.16,-17.69,;33.18,-20.06,;33.18,-18.52,;31.84,-17.75,;30.52,-18.52,;29.18,-17.75,;29.18,-16.21,;27.84,-15.44,;30.51,-15.44,;31.84,-16.2,;31.85,-20.83,)| Show InChI InChI=1S/C26H38N6O5S/c1-2-3-4-13-27-26-28-18-23(24(31-26)29-19-5-9-21(33)10-6-19)25(34)30-20-7-11-22(12-8-20)38(35,36)32-14-16-37-17-15-32/h7-8,11-12,18-19,21,33H,2-6,9-10,13-17H2,1H3,(H,30,34)(H2,27,28,29,31)/t19-,21-	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	27	n/a	n/a	n/a	n/a	n/a	n/a
Eshelman School of Pharmacy�Department of Pharmacology�Lineberger Compreh Curated by ChEMBL					Assay Description Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay				J Med Chem 56: 9693-700 (2014) Article DOI: 10.1021/jm4013888 BindingDB Entry DOI: 10.7270/Q21G0NQ1
					More data for this Ligand-Target Pair
Tyrosine-protein kinase receptor UFO (Homo sapiens (Human))	BDBM50444272 (CHEMBL3093626) Show SMILES CCCCCNc1ncc(C(=O)Nc2ccc(cc2)S(=O)(=O)N2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1 |r,wU:30.31,wD:33.35,(23.85,-22.37,;25.18,-23.14,;26.52,-22.37,;27.85,-23.14,;29.18,-22.37,;30.52,-23.14,;31.85,-22.37,;33.19,-23.14,;34.52,-22.37,;34.52,-20.82,;35.85,-20.05,;35.84,-18.51,;37.18,-20.81,;38.52,-20.04,;39.85,-20.81,;41.18,-20.03,;41.17,-18.49,;39.83,-17.73,;38.5,-18.51,;42.5,-17.71,;41.73,-16.37,;43.27,-16.37,;43.84,-18.48,;43.84,-20.01,;45.17,-20.78,;46.5,-20.01,;46.5,-18.46,;45.16,-17.69,;33.18,-20.06,;33.18,-18.52,;31.84,-17.75,;30.52,-18.52,;29.18,-17.75,;29.18,-16.21,;27.84,-15.44,;30.51,-15.44,;31.84,-16.2,;31.85,-20.83,)| Show InChI InChI=1S/C26H38N6O5S/c1-2-3-4-13-27-26-28-18-23(24(31-26)29-19-5-9-21(33)10-6-19)25(34)30-20-7-11-22(12-8-20)38(35,36)32-14-16-37-17-15-32/h7-8,11-12,18-19,21,33H,2-6,9-10,13-17H2,1H3,(H,30,34)(H2,27,28,29,31)/t19-,21-	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.10E+3	n/a	n/a	n/a	n/a	n/a	n/a
Eshelman School of Pharmacy�Department of Pharmacology�Lineberger Compreh Curated by ChEMBL					Assay Description Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay				J Med Chem 56: 9693-700 (2014) Article DOI: 10.1021/jm4013888 BindingDB Entry DOI: 10.7270/Q21G0NQ1
					More data for this Ligand-Target Pair
Tyrosine-protein kinase receptor TYRO3 (Homo sapiens (Human))	BDBM50444272 (CHEMBL3093626) Show SMILES CCCCCNc1ncc(C(=O)Nc2ccc(cc2)S(=O)(=O)N2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1 |r,wU:30.31,wD:33.35,(23.85,-22.37,;25.18,-23.14,;26.52,-22.37,;27.85,-23.14,;29.18,-22.37,;30.52,-23.14,;31.85,-22.37,;33.19,-23.14,;34.52,-22.37,;34.52,-20.82,;35.85,-20.05,;35.84,-18.51,;37.18,-20.81,;38.52,-20.04,;39.85,-20.81,;41.18,-20.03,;41.17,-18.49,;39.83,-17.73,;38.5,-18.51,;42.5,-17.71,;41.73,-16.37,;43.27,-16.37,;43.84,-18.48,;43.84,-20.01,;45.17,-20.78,;46.5,-20.01,;46.5,-18.46,;45.16,-17.69,;33.18,-20.06,;33.18,-18.52,;31.84,-17.75,;30.52,-18.52,;29.18,-17.75,;29.18,-16.21,;27.84,-15.44,;30.51,-15.44,;31.84,-16.2,;31.85,-20.83,)| Show InChI InChI=1S/C26H38N6O5S/c1-2-3-4-13-27-26-28-18-23(24(31-26)29-19-5-9-21(33)10-6-19)25(34)30-20-7-11-22(12-8-20)38(35,36)32-14-16-37-17-15-32/h7-8,11-12,18-19,21,33H,2-6,9-10,13-17H2,1H3,(H,30,34)(H2,27,28,29,31)/t19-,21-	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.19E+4	n/a	n/a	n/a	n/a	n/a	n/a
Eshelman School of Pharmacy�Department of Pharmacology�Lineberger Compreh Curated by ChEMBL					Assay Description Inhibition of Tyro-3 kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis as...				J Med Chem 56: 9693-700 (2014) Article DOI: 10.1021/jm4013888 BindingDB Entry DOI: 10.7270/Q21G0NQ1
					More data for this Ligand-Target Pair